384 related articles for article (PubMed ID: 14758577)
1. Olanzapine versus placebo in the treatment of psychosis with or without associated behavioral disturbances in patients with Alzheimer's disease.
De Deyn PP; Carrasco MM; Deberdt W; Jeandel C; Hay DP; Feldman PD; Young CA; Lehman DL; Breier A
Int J Geriatr Psychiatry; 2004 Feb; 19(2):115-26. PubMed ID: 14758577
[TBL] [Abstract][Full Text] [Related]
2. Comparison of olanzapine and risperidone in the treatment of psychosis and associated behavioral disturbances in patients with dementia.
Deberdt WG; Dysken MW; Rappaport SA; Feldman PD; Young CA; Hay DP; Lehman DL; Dossenbach M; Degenhardt EK; Breier A
Am J Geriatr Psychiatry; 2005 Aug; 13(8):722-30. PubMed ID: 16085789
[TBL] [Abstract][Full Text] [Related]
3. The effects of olanzapine in reducing the emergence of psychosis among nursing home patients with Alzheimer's disease.
Clark WS; Street JS; Feldman PD; Breier A
J Clin Psychiatry; 2001 Jan; 62(1):34-40. PubMed ID: 11235926
[TBL] [Abstract][Full Text] [Related]
4. Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group.
Street JS; Clark WS; Gannon KS; Cummings JL; Bymaster FP; Tamura RN; Mitan SJ; Kadam DL; Sanger TM; Feldman PD; Tollefson GD; Breier A
Arch Gen Psychiatry; 2000 Oct; 57(10):968-76. PubMed ID: 11015815
[TBL] [Abstract][Full Text] [Related]
5. Correlates of anticholinergic activity in patients with dementia and psychosis treated with risperidone or olanzapine.
Mulsant BH; Gharabawi GM; Bossie CA; Mao L; Martinez RA; Tune LE; Greenspan AJ; Bastean JN; Pollock BG
J Clin Psychiatry; 2004 Dec; 65(12):1708-14. PubMed ID: 15641877
[TBL] [Abstract][Full Text] [Related]
6. Long-term efficacy of olanzapine in the control of psychotic and behavioral symptoms in nursing home patients with Alzheimer's dementia.
Street JS; Clark WS; Kadam DL; Mitan SJ; Juliar BE; Feldman PD; Breier A
Int J Geriatr Psychiatry; 2001 Dec; 16 Suppl 1():S62-70. PubMed ID: 11748789
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of olanzapine in the treatment of psychosis in dementia with lewy bodies.
Cummings JL; Street J; Masterman D; Clark WS
Dement Geriatr Cogn Disord; 2002; 13(2):67-73. PubMed ID: 11844887
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the safety, tolerability, and efficacy of pimavanserin versus placebo in patients with Alzheimer's disease psychosis: a phase 2, randomised, placebo-controlled, double-blind study.
Ballard C; Banister C; Khan Z; Cummings J; Demos G; Coate B; Youakim JM; Owen R; Stankovic S;
Lancet Neurol; 2018 Mar; 17(3):213-222. PubMed ID: 29452684
[TBL] [Abstract][Full Text] [Related]
9. Aripiprazole for the treatment of psychoses in institutionalized patients with Alzheimer dementia: a multicenter, randomized, double-blind, placebo-controlled assessment of three fixed doses.
Mintzer JE; Tune LE; Breder CD; Swanink R; Marcus RN; McQuade RD; Forbes A
Am J Geriatr Psychiatry; 2007 Nov; 15(11):918-31. PubMed ID: 17974864
[TBL] [Abstract][Full Text] [Related]
10. Effect of olanzapine on cognition during treatment of behavioral and psychiatric symptoms in patients with dementia: a post-hoc analysis.
Deberdt WG; Siegal A; Ahl J; Meyers AL; Landbloom R
Int J Geriatr Psychiatry; 2008 Apr; 23(4):364-9. PubMed ID: 17708584
[TBL] [Abstract][Full Text] [Related]
11. Risperidone, olanzapine and quetiapine in the treatment of behavioral and psychological symptoms in patients with Alzheimer's disease: preliminary findings from a naturalistic, retrospective study.
Rocca P; Marino F; Montemagni C; Perrone D; Bogetto F
Psychiatry Clin Neurosci; 2007 Dec; 61(6):622-9. PubMed ID: 18081622
[TBL] [Abstract][Full Text] [Related]
12. Clinical symptom responses to atypical antipsychotic medications in Alzheimer's disease: phase 1 outcomes from the CATIE-AD effectiveness trial.
Sultzer DL; Davis SM; Tariot PN; Dagerman KS; Lebowitz BD; Lyketsos CG; Rosenheck RA; Hsiao JK; Lieberman JA; Schneider LS;
Am J Psychiatry; 2008 Jul; 165(7):844-54. PubMed ID: 18519523
[TBL] [Abstract][Full Text] [Related]
13. Olanzapine does not enhance cognition in non-agitated and non-psychotic patients with mild to moderate Alzheimer's dementia.
Kennedy J; Deberdt W; Siegal A; Micca J; Degenhardt E; Ahl J; Meyers A; Kaiser C; Baker RW
Int J Geriatr Psychiatry; 2005 Nov; 20(11):1020-7. PubMed ID: 16250069
[TBL] [Abstract][Full Text] [Related]
14. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
[TBL] [Abstract][Full Text] [Related]
15. Risperidone for psychosis of Alzheimer's disease and mixed dementia: results of a double-blind, placebo-controlled trial.
Brodaty H; Ames D; Snowdon J; Woodward M; Kirwan J; Clarnette R; Lee E; Greenspan A
Int J Geriatr Psychiatry; 2005 Dec; 20(12):1153-7. PubMed ID: 16315159
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the efficacy of new and conventional antipsychotic drugs in the treatment of behavioral and psychological symptoms of dementia (BPSD).
Gareri P; Cotroneo A; Lacava R; Seminara G; Marigliano N; Loiacono A; De Sarro G
Arch Gerontol Geriatr Suppl; 2004; (9):207-15. PubMed ID: 15207416
[TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind, placebo-controlled study of aripiprazole for the treatment of psychosis in nursing home patients with Alzheimer disease.
Streim JE; Porsteinsson AP; Breder CD; Swanink R; Marcus R; McQuade R; Carson WH
Am J Geriatr Psychiatry; 2008 Jul; 16(7):537-50. PubMed ID: 18591574
[TBL] [Abstract][Full Text] [Related]
18. Aripiprazole for the treatment of psychosis in patients with Alzheimer's disease: a randomized, placebo-controlled study.
De Deyn P; Jeste DV; Swanink R; Kostic D; Breder C; Carson WH; Iwamoto T
J Clin Psychopharmacol; 2005 Oct; 25(5):463-7. PubMed ID: 16160622
[TBL] [Abstract][Full Text] [Related]
19. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
[TBL] [Abstract][Full Text] [Related]
20. Quetiapine treatment for behavioural and psychological symptoms of dementia in Alzheimer's disease patients: a 6-week, double-blind, placebo-controlled study.
Paleacu D; Barak Y; Mirecky I; Mazeh D
Int J Geriatr Psychiatry; 2008 Apr; 23(4):393-400. PubMed ID: 17879256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
